Excellence in Cytometry
Cytek Biosciences Inc. is the outcome of a merger between Cytek Development Inc, a leading pioneer in flow cytometry, and Cytoville Inc, a venture capital backed business in advanced medical instrument technology development. Cytek was founded by Dr. Eric Chase 25 years ago, and is a leading manufacturer and supplier of flow cytometry products and services. We are engineers, scientists and customer service representatives who design, build and support flow cytometers. Cytek Biosciences is backed by Cowin Healthcare Fund, Easy Prosperity and Fidelity Biosciences.
Our mission is to create innovative products and services which lead to scientific discovery.
Our novel, cost-effective products assist labs around the world to operate safely and efficiently. Cytek's products add functionality to existing flow cytometry equipment, extending its usable life. Our onsite support services, provide cost effective maintenance solutions for a broad range of laboratories.
As a Company, we seek to maintain high ethical standards and a culture that values honesty, integrity and transparency in all that we do. Company decisions are driven by what is right for scientific discovery and customer support. We are committed to our employees, to the environment in which we live and to the communities we serve worldwide.
Wenbin Jiang Ph.D.- Cytek Biosciences, C.E.O.
Dr Jiang is a seasoned entrepreneur and inventor. E2O communications was the first company he cofounded in late 1990s, which was acquired by JDS Uniphase in 2004. He is an inventor of more than 90 US patents and an author of 4 book chapters and more than 50 peer reviewed technical papers.
Eric Chase Ph.D.- Cytek Biosciences, Director
Dr. Chase founded Cytek Development and was CEO for 25 years. He holds 4 patents in the areas of flow cytometry and sample preparation, and has extensive expertise in flow cytometer design.
Kevin Yan- President, Innovex Medical Co., Ltd
Jenny Rooke Ph.D.- Venture Partner, Fidelity Biosciences
Dr. Rooke brings a combination of strategy, operating, and investing experience to her role as Venture Partner. She focuses on early stage life science companies on the west coast, specializing in research tools, diagnostics, and synthetic biology.